Nancy T. B.
- Country
- Austria
- Department
- Department of Surgery
Research Overview
- Phase III Randomized Trial of Palbociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR+/HER2- Early Breast Cancer
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
Data & Insights
Has run more than one trial at 62 of 296 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in hormone receptor-positive (HR+) and HER2-negative breast cancer treatment approaches, with particular focus on developing enhanced therapeutic strategies for early-stage disease management.
- Early Breast Cancer Treatment
- Endocrine Therapy Optimization
- Targeted Therapeutic Approaches
Their research concentrates on improving patient outcomes through innovative combinations of endocrine therapy and targeted treatments.
Therapeutic Development
The investigator explores adjuvant treatment strategies for breast cancer, focusing on enhancing standard therapeutic protocols with novel targeted agents.
- Long-term Treatment Protocols
- Combination Therapy Approaches
- Disease-free Survival Optimization
Their work examines extended duration treatments and their impact on invasive disease-free survival.
Clinical Innovation
The investigator evaluates novel therapeutic combinations in early-stage breast cancer treatment, seeking to establish more effective treatment paradigms.
- Treatment Duration Assessment
- Therapeutic Response Evaluation
- Patient Outcome Enhancement
Their research aims to advance the understanding of optimal treatment durations in early breast cancer management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.